Medicine and Dentistry
Systematic Review
94%
Wart Virus
83%
Oropharynx Squamous Cell Carcinoma
77%
Head and Neck Cancer
61%
Squamous Cell Carcinoma
46%
Oral Cavity
42%
Severe Acute Respiratory Syndrome Coronavirus 2
39%
Meta-Analysis
33%
Xerostomia
29%
Overall Survival
28%
Mouth Squamous Cell Carcinoma
26%
Oropharyngeal Cancer
26%
Recurrent Disease
25%
Neoplasm
23%
COVID-19
23%
Hyposalivation
23%
Malignant Neoplasm
21%
Oral Cancer
20%
Prevalence
20%
Throat Culture
19%
P16
19%
Adipose Tissue
18%
Relative Survival
18%
Case-Control Study
17%
Neck
17%
Retrospective Study
16%
Salivary Gland
16%
Disease
15%
Stromal Cell
15%
Thyroid Cancer
15%
Liquid Biopsy
15%
Tonsil
15%
Salivation
15%
Mesenchymal Stem Cell Transplantation
14%
Placebo
14%
Cancer
14%
Nose Smear
14%
Hazard Ratio
13%
Retrospective Cohort Study
12%
Time to Treatment
12%
Reverse Transcription Polymerase Chain Reaction
12%
Oropharynx Carcinoma
11%
Radiation Therapy
11%
Mesenchymal Stem Cell
11%
Stem Cell Therapy
11%
Nasopharyngeal Swab
11%
Recurrence Free Survival
10%
Tongue
10%
Survival Rate
10%
Second Cancer
10%
Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
High-risk Human Papillomavirus (HR-HPV)
72%
Head-and-neck Cancer
65%
Denmark
64%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
56%
Meta-analysis
32%
Systematic Meta-analysis
31%
Mesenchymal Stromal Cells
29%
COVID-19
29%
Overall Survival
27%
Radiation Effects
26%
Incidence Rate
25%
Cancer Patients
25%
Age-specific Incidence
23%
Population-based
21%
Mesenchymal Stem Cell Therapy
20%
Comorbidity
20%
Oropharyngeal
20%
Xerostomia
19%
Relative Survival
19%
Tumor
18%
5-year Survival
18%
Hyposalivation
18%
SARS-CoV-2 Detection
17%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
17%
Nasopharyngeal Swab
17%
Population-based Study
16%
HPV Positive
16%
Liquid Biopsy
15%
Rapid Antigen Test
15%
Stem Cell Therapy
15%
Throat Swab
15%
Tonsil
15%
Quantitative PCR
15%
Copenhagen
14%
Embase
14%
Salivary Gland Diseases
13%
Locoregional Recurrence
13%
Danish Population
13%
Saliva
13%
Retrospective Cohort Study
12%
Head-and-neck
12%
PubMed
12%
Survival Outcomes
12%
Average Annual Percent Change
11%
Population-based Case-control Study
10%
Oral Cavity Cancer
10%
Second Primary Cancer
10%
Thyroid Cancer
10%
Randomized Placebo-controlled Trial
10%